Chemoprevention of bladder cancer

被引：0
|
作者：
Dragan J. Golijanin
David Kakiashvili
Ralph R. Madeb
Edward M. Messing
Seth P. Lerner
机构：
[1] University of Rochester Medical Center,Urology Department
[2] Baylor College of Medicine,Scott Department of Urology
来源：
World Journal of Urology | 2006年 / 24卷
关键词：
Bladder Cancer; Genistein; Urothelial Carcinoma; Chemopreventive Agent; Urothelial Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：445 / 472
页数：27
相关论文
共 50 条
  • [1] Isothiocyanates in the chemoprevention of bladder cancer
    Tang, L
    Zhang, YS
    CURRENT DRUG METABOLISM, 2004, 5 (02) : 193 - 201
  • [2] Chemoprevention of superficial bladder cancer
    Gee, J
    Sabicihi, AL
    Grossman, HB
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 43 (03) : 277 - 286
  • [3] CHEMOPREVENTION OF EXPERIMENTAL BLADDER-CANCER
    MOON, RC
    DETRISAC, CJ
    THOMAS, CF
    KELLOFF, GJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1992, : 134 - 138
  • [4] Targeting Inflammation for Bladder Cancer Chemoprevention
    Madka V.
    Asch A.S.
    Rao C.V.
    Current Pharmacology Reports, 2017, 3 (6) : 447 - 457
  • [5] Bladder Cancer: Chemoprevention, complementary approaches and budgetary considerations
    Grossman, H. Barton
    Stenzl, Arnulf
    Moyad, Mark A.
    Droller, Michael J.
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2008, 42 : 213 - 233
  • [6] Hormetic or Biphasic Effects of Sulforaphane in Chemoprevention of Bladder Cancer
    He, Canxia
    Zhang, Xiaohong
    ANNALS OF NUTRITION AND METABOLISM, 2019, 75 : 282 - 282
  • [7] Sulforaphane for the chemoprevention of bladder cancer: molecular mechanism targeted approach
    Leone, Andrew
    Diorio, Gregory
    Sexton, Wade
    Schell, Michael
    Alexandrow, Mark
    Fahey, Jed W.
    Kumar, Nagi B.
    ONCOTARGET, 2017, 8 (21) : 35412 - 35424
  • [8] Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium
    Maria E Goossens
    Frank Buntinx
    Steven Joniau
    Koen Ackaert
    Filip Ameye
    Ignace Billiet
    Johan Braeckman
    Alex Breugelmans
    Jochen Darras
    Kurt Dilen
    Lieven Goeman
    Eliane Kellen
    Bertrand Tombal
    Siska Van Bruwaene
    Ben Van Cleyenbreuge
    Frank Van der Aa
    Kris Vekemans
    Hendrik Van Poppel
    Maurice P Zeegers
    BMC Urology, 12
  • [9] Designing the selenium and bladder cancer trial (SELEBLAT), a phase III randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium
    Goossens, Maria E.
    Buntinx, Frank
    Joniau, Steven
    Ackaert, Koen
    Ameye, Filip
    Billiet, Ignace
    Braeckman, Johan
    Breugelmans, Alex
    Darras, Jochen
    Dilen, Kurt
    Goeman, Lieven
    Kellen, Eliane
    Tombal, Bertrand
    Van Bruwaene, Siska
    Van Cleyenbreuge, Ben
    Van der Aa, Frank
    Vekemans, Kris
    Van Poppel, Hendrik
    Zeegers, Maurice P.
    BMC UROLOGY, 2012, 12
  • [10] Cancer Chemoprevention
    Omer Kucuk
    Cancer and Metastasis Reviews, 2002, 21 : 189 - 197
12345